128 related articles for article (PubMed ID: 29086373)
1. Detection of Plasma MicroRNA Signature in Osteosarcoma Patients.
Allen-Rhoades W; Yustein JT
Methods Mol Biol; 2018; 1699():113-118. PubMed ID: 29086373
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.
Shi L; Xie C; Zhu J; Chen X
Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
4. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
5. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
Allen-Rhoades W; Kurenbekova L; Satterfield L; Parikh N; Fuja D; Shuck RL; Rainusso N; Trucco M; Barkauskas DA; Jo E; Ahern C; Hilsenbeck S; Donehower LA; Yustein JT
Cancer Med; 2015 Jul; 4(7):977-88. PubMed ID: 25784290
[TBL] [Abstract][Full Text] [Related]
6. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
[TBL] [Abstract][Full Text] [Related]
7. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
Zhang C; Yao C; Li H; Wang G; He X
Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.
Ma W; Zhang X; Chai J; Chen P; Ren P; Gong M
Tumour Biol; 2014 Dec; 35(12):12467-72. PubMed ID: 25185654
[TBL] [Abstract][Full Text] [Related]
12. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Diao ZB; Sun TX; Zong Y; Lin BC; Xia YS
J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712
[TBL] [Abstract][Full Text] [Related]
14. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
16. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
Yuan J; Chen L; Chen X; Sun W; Zhou X
J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
[TBL] [Abstract][Full Text] [Related]
17. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.
Cao L; Wang J; Wang PQ
Biomed Pharmacother; 2016 Dec; 84():828-835. PubMed ID: 27723574
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
19. Identification of Biomarkers for Osteosarcoma Based on Integration Strategy.
Bao J; Song Z; Song C; Wang Y; Li W; Mai W; Shi Q; Yu H; Ni L; Liu Y; Lu X; He C; Chen L; Qu G
Med Sci Monit; 2020 Mar; 26():e920803. PubMed ID: 32173717
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]